logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Elderly AML: ATRA combination offers promise in patients unfit for induction chemotherapy

No meaningful increase in toxicities vs decitabine monotherapy.